文献速递中毒与环境急症消化、代谢与肾脏急症

以LSD名义出售的粉末致25B-NBOH中毒聚集性病例

A cluster of 25B-NBOH poisonings following exposure to powder sold as lysergic acid diethylamide (LSD).
PubMed 文献 · Clin Toxicol (Phila) · 2022-03-28
一句话结论25B-NBOH粉末中毒可致瞳孔散大、心动过速、高血压、严重激越及鼻吸后快速起病的癫痫持续状态,毒性12小时内消退,未见高热。

本文报告5例在聚会中接触以「粉末LSD」名义出售的粉末后急诊就诊的患者。1例24岁男性吞服后出现瞳孔散大、心动过速、高血压和严重激越,需胃肠外镇静;1例22岁男性鼻吸后出现癫痫持续状态需插管;两例均发生急性肾损伤,其中1例横纹肌溶解,血检均检出25-NBOH且无其他违禁或合法药物。另3例仅轻度幻觉。作者指出,25B-NBOH粉末暴露产生拟交感毒性,鼻吸可致癫痫持续状态快速起病,毒性均在12小时内消退,尽管体外证据显示5-HT2A受体激动作用,但未观察到高热。

要点

  • 鼻吸25B-NBOH粉末可致癫痫持续状态快速起病,22岁男性需插管;吞服者出现严重激越需胃肠外镇静。
  • 两例重症均发生急性肾损伤,其中1例伴横纹肌溶解;血检检出25-NBOH且无其他违禁或合法药物。
  • 所有病例毒性均在12小时内消退,未记录到高热,尽管体外证据显示5-HT2A受体激动作用。
  • 以「粉末LSD」名义出售的粉末可能是25B-NBOH等强效拟交感物质,少量暴露即可致严重毒性。
  • 5例中3例仅轻度幻觉,提示同一来源粉末暴露的临床严重度差异大。

适用人群与场景

  • 在聚会中接触以「粉末LSD」名义出售的粉末后出现意识状态改变而就诊急诊的患者。

处置流程与药物剂量

  • 出现严重激越者需胃肠外镇静。
  • 出现癫痫持续状态者需插管。

红旗征与不能漏的情况

  • 鼻吸25B-NBOH粉末后快速起病的癫痫持续状态,需插管。
  • 吞服25B-NBOH粉末后严重激越,需胃肠外镇静。
  • 急性肾损伤,其中1例伴横纹肌溶解。

研究设计与关键结果

  • 病例系列:5例患者因接触以「粉末LSD」名义出售的粉末后意识状态改变就诊急诊;24岁男性吞服后出现瞳孔散大、心动过速、高血压和严重激越需胃肠外镇静;22岁男性鼻吸后出现癫痫持续状态需插管;两例均发生急性肾损伤,其中1例横纹肌溶解,血检均检出25-NBOH且无其他违禁或合法药物;另3例出现轻度幻觉;未记录到高热;所有病例毒性均在12小时内消退。

证据类型、等级与局限

  • 证据类型:病例系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些病例中记录的严重临床毒性凸显了接触看似少量强效拟交感物质即可能产生不良健康效应的潜力。
  • 强效致幻剂常通过吸墨纸递送以避免过量给药。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: 25B-NBOH is a synthetic hallucinogen closely related to the "NBOMe" family of N-substituted 2C phenethylamine derivatives. There have been no published reports documenting the clinical toxicity of NBOH derivatives.

CASE SERIES: Five patients presented to the Emergency Department (ED) with altered conscious state following exposure to powder sold as "powdered LSD" at a party. A 24-year-old male who ingested the powder developed mydriasis, tachycardia, hypertension, and severe agitation requiring parenteral sedation. A 22-year-old male who insufflated the powder developed status epilepticus requiring intubation. Both patients developed acute kidney injury and one had rhabdomyolysis. In both cases, blood analysis detected 25-NBOH and no other illicit/licit drugs. Three other patients developed mild hallucinations. Hyperthermia was not documented in any case.

DISCUSSION: Exposure to 25B-NBOH in a powdered form produced sympathomimetic toxicity, including hallucinations. Insufflation of 25B-NBOH led to rapid onset of status epilepticus in one case. Toxicity in all cases resolved within 12 h. Despite in vitro evidence of 5-HT2A receptor agonism, hyperthermia was not observed. Potent hallucinogens are often delivered via blotter paper to avoid excessive dosing. The severe clinical toxicity documented in these cases highlights the potential for development of adverse health effects with exposure to apparent small volumes of potent sympathomimetics.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Ivory ST, Rotella JA, Schumann J, et al. A cluster of 25B-NBOH poisonings following exposure to powder sold as lysergic acid diethylamide (LSD). Clin Toxicol (Phila). 2022. PMID: 35343858. doi:10.1080/15563650.2022.2053150

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。